These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 33234142)

  • 1. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
    Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
    J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR-375.
    Li L; Xiao C; He K; Xiang G
    IUBMB Life; 2021 Sep; 73(9):1153-1165. PubMed ID: 34148288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircSOD2 Contributes to Tumor Progression, Immune Evasion and Anti-PD-1 Resistance in Hepatocellular Carcinoma by Targeting miR-497-5p/ANXA11 Axis.
    Ye R; Lu X; Liu J; Duan Q; Xiao J; Duan X; Yue Z; Liu F
    Biochem Genet; 2023 Apr; 61(2):597-614. PubMed ID: 36008700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
    Lv J; Kong Y; Gao Z; Liu Y; Zhu P; Yu Z
    Int J Biochem Cell Biol; 2018 Aug; 101():19-28. PubMed ID: 29791864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircRNA SOD2 motivates non-small cell lungs cancer advancement with EMT via acting as microRNA-2355-5p's competing endogenous RNA to mediate calmodulin regulated spectrin associated proteins-2.
    Lv C; Hu Y; Zhou X; Zhu Y; Wang J; Zhou F
    Bioengineered; 2022 Mar; 13(3):5756-5768. PubMed ID: 35188072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA-324-5p/cyclin-dependent kinase 16 axis.
    Zhao JA; Nie W; Dong L; Liu W; Wei W
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2967-2977. PubMed ID: 33982329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
    Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
    Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel circular RNA circ-LRIG3 facilitates the malignant progression of hepatocellular carcinoma by modulating the EZH2/STAT3 signaling.
    Sun S; Gao J; Zhou S; Li Y; Wang Y; Jin L; Li J; Liu B; Zhang B; Han S; Ding H; Li X
    J Exp Clin Cancer Res; 2020 Nov; 39(1):252. PubMed ID: 33222697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
    Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
    EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propofol induces hepatocellular carcinoma cell apoptosis via regulating miR-105/JAK2/STAT3 axis.
    Li J; Liu M; Zeng B; Wang Z
    Cytokine; 2021 Dec; 148():155649. PubMed ID: 34388478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA-ABCB10 suppresses hepatocellular carcinoma progression through upregulating NRP1/ABL2 via sponging miR-340-5p/miR-452-5p.
    Yang W; Ju HY; Tian XF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2347-2357. PubMed ID: 32196586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive adsorption of microRNA-532-3p by circular RNA SOD2 activates Thioredoxin Interacting Protein/NLR family pyrin domain containing 3 pathway and promotes pyroptosis of non-alcoholic fatty hepatocytes.
    Chen F; Xing Y; Chen Z; Chen X; Li J; Gong S; Luo F; Cai Q
    Eur J Med Res; 2024 Apr; 29(1):250. PubMed ID: 38659023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.
    Shi X; Liu TT; Yu XN; Balakrishnan A; Zhu HR; Guo HY; Zhang GC; Bilegsaikhan E; Sun JL; Song GQ; Weng SQ; Dong L; Ott M; Zhu JM; Shen XZ
    Oncogene; 2020 Aug; 39(35):5768-5781. PubMed ID: 32719439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
    Huang B; Huang M; Li Q
    Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling.
    Yang L; Xue H; Sun Y; Zhang L; Xue F; Ge R
    Cell Death Dis; 2020 Jul; 11(7):605. PubMed ID: 32732872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA SNHG14 promotes hepatocellular carcinoma progression by regulating miR-876-5p/SSR2 axis.
    Liao Z; Zhang H; Su C; Liu F; Liu Y; Song J; Zhu H; Fan Y; Zhang X; Dong W; Chen X; Liang H; Zhang B
    J Exp Clin Cancer Res; 2021 Jan; 40(1):36. PubMed ID: 33485374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway.
    Li SJ; Sui MH; Sun ZX; Zhang WW
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1038-1046. PubMed ID: 30779070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extract of
    Huang X; Chen Y; Zhang X; Li F; Ye H
    Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841
    [No Abstract]   [Full Text] [Related]  

  • 20. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.